PCD Pharma Franchise Opportunities in Mizoram with Daksh Diabetes and Cardiac Care
Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are emerging as significant health challenges in Mizoram. The state has shown an increase in cases of type 2 diabetes mellitus over the last few decades. A study among young adults in Aizawl found that 35% had a slightly elevated risk for type 2 diabetes, with a further 5% at moderate risk. Raised blood glucose was reported in 5.4% of the adult population.
The burden of hypertension is equally concerning. Among adults, 49% are prehypertensive and 14.4% have Stage 1 hypertension. A community-based study found that 11.97% of individuals were hypertensive. Additionally, nearly half of the population has a clustering of three or more cancer and NCD risk factors.
The primary drivers include the unique Mizoram dietary and lifestyle habits. The study identified fermented pork fat (Sa-um) as a potential risk factor for type 2 diabetes with an odds ratio of 18.98, along with tuibur (tobacco-infused water). Other contributing factors include smoked meat, excess salt consumption, betel leaf with areca nut chewing, alcohol consumption, and physical inactivity. The state also has one of the highest rates of tobacco use (77.1%) and consumption of fermented products (80%).
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Mizoram families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes.
How Daksh is making a Difference in Mizoram
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Mizoram patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Mizoram
Daksh works with hospitals, clinics, and pharmacies across Mizoram to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
With the state’s high disease burden and growing healthcare sector, there is immense potential to build a meaningful healthcare business while serving your community.
Popular Locations for PCD Pharma Franchise in Mizoram
| PCD / Franchise Keywords | Product / Therapy Keywords |
| PCD pharma franchise in Aizawl | Cardiac diabetic PCD company in Aizawl |
| PCD pharma franchise in Lunglei | Cardiac diabetic products in Lunglei |
| PCD pharma franchise in Champhai | Diabetic cardiac PCD franchise in Champhai |
| PCD pharma franchise in Serchhip | Cardiac diabetic PCD company in Serchhip |
| PCD pharma franchise in Kolasib | Cardiac diabetic products in Kolasib |
| PCD pharma franchise in Lawngtlai | Diabetic cardiac PCD franchise in Lawngtlai |
| PCD pharma franchise in Mamit | Cardiac diabetic PCD company in Mamit |
| PCD pharma franchise in Saiha | Cardiac diabetic products in Saiha |
| PCD pharma franchise in Hnahthial | Diabetic cardiac PCD franchise in Hnahthial |
| PCD pharma franchise in Saitual | Cardiac diabetic PCD company in Saitual |
Conclusion
The diabetes and heart disease burden in Mizoram is not just a statistic—it is a reality affecting thousands of families. With the state recording a hypertension prevalence of 11.97%, 49% prehypertensive, and 35% slightly elevated diabetes risk, and 77.1% tobacco use, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 |
| enquirypurchase.daksh@gmail.com | |
| Contact us | https://diabetes-cardiac.com/contact-us/ |